Dr. Lee’s TeaForHealth^® will present the only green tea product with a qualified health claim from the U.S. Food and Drug Administration (FDA) based on the de facto standard recommended by the National Cancer Institute (NCI) for effectiveness against cancer.

Based on the pharmaco-dynamics data published by the NCI in 1996, the anti-cancer health benefit of green tea is dose-dependent. The lowest anticancer dose is 800 ml (27 oz.) of green tea containing 710 mcg/ml (-) epigallocatechin gallate (EGCG) per day in an adult, which is about two bottles of Dr. Lee's 710EGCG™ organic green tea inabottle™, or about 68 bottles of Snapple^® per day, or 112 bottles of SoBe^® green tea per day.

The new TeaForHealth 710EGCG organic green tea inabottle product, in four ready-to-drink flavors, will be available for tasting at the Summer Fancy Food Show at the Jacob K. Javits Center in New York from July 9-11, 2006.

Snapple is a registered trademark of Snapple Beverage Corp., Rye Brook, NY.
SoBe is a registered trademark of South Beach Beverage Company, Inc., Norwalk, CT.

Dr. Lee to Present “Green Tea as Medicine to Fight Cancer” at UICC World Cancer Congress in Washington, D.C.

On July 10, 2006, Dr. Sin H. Lee will present the scientific evidence upon which the FDA granted the qualified health claim for green tea to the quadrennial World Cancer Congress of the International Union Against Cancer (UICC), in Washington, D.C.

The UICC World Cancer Congress 2006 will bring together the world's foremost cancer control leaders and practitioners in an effort to reduce the global cancer burden.

Give the gift of health on their special dayswith TeaForHealth^® Starter Sets. 

Save more than 15%!

E-mail us to receive the latest in green tea news and updates at news@teaforhealth.com!